Biogen Idec to Use Almac Technology to Extract Genetic Material from Samples | GenomeWeb
NEW YORK (GenomeWeb News) – Biogen Idec will use Almac Diagnostics’ expertise in extracting genetic information from formalin-fixed paraffin embedded tissue, Almac said yesterday.
 
Craigavon, Northern Ireland-based Almac said that Biogen Idec would use the process for SNP analysis in a phase II study of a drug for treating gastrointestinal stromal tumors. The firm’s process enables researchers to use FFPE samples in qPCR and microarray SNP genotyping and gene expression studies.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.